{"created":"2023-06-20T15:47:55.437616+00:00","id":2439,"links":{},"metadata":{"_buckets":{"deposit":"2082b7bc-56da-4d26-bc26-23b353ffb7b9"},"_deposit":{"created_by":4,"id":"2439","owners":[4],"pid":{"revision_id":0,"type":"depid","value":"2439"},"status":"published"},"_oai":{"id":"oai:hama-med.repo.nii.ac.jp:00002439","sets":["1:11"]},"author_link":[],"item_3_biblio_info_5":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"1990-12-20","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"12","bibliographicPageEnd":"1476","bibliographicPageStart":"1471","bibliographicVolumeNumber":"54","bibliographic_titles":[{"bibliographic_title":"Japanese Circulation Journal"}]}]},"item_3_description_9":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"To study the tissue carnitine level in patients with chronic heart failure, we obtained biopsy specimens of the left ventricular papillary muscle from 8 patients with mitral valve disease undergoing valve replacement surgery. As a control group autopsy specimens from 7 patients without heart disease were obtained within 4 hours of death. The free carnitine level in the heart was significantly lower in patients with chronic heart failure than in the control group (412±142 nmol/g wet tissue vs 769±267; p<0.01, mean±SD). The long-chain acylcarnitine level was significantly higher in chronic heart failure than in the control group (532±169 nmol/g wet tissue vs 317±72; p<0.01). The total carnitine level in chronic heart failure was similar to that in the control group (1321±170 nmol/g wet tissue vs 1315±377) . These results show that in failing myocardium the fatty acid metabolism may be impaired, and administration of carnitine may be worth trying to treat chronic heart failure.","subitem_description_type":"Abstract"}]},"item_3_publisher_6":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"日本循環器学会"}]},"item_3_relation_28":{"attribute_name":"出版社DOI","attribute_value_mlt":[{"subitem_relation_type":"isIdenticalTo","subitem_relation_type_id":{"subitem_relation_type_id_text":"10.1253/jcj.54.12_1471","subitem_relation_type_select":"DOI"}}]},"item_3_rights_7":{"attribute_name":"権利","attribute_value_mlt":[{"subitem_rights":"Copyright日本循環器学会"},{"subitem_rights":"本文データは学協会の許諾に基づきJournal Archiveから複製したものである"}]},"item_3_source_id_19":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"00471828","subitem_source_identifier_type":"ISSN"}]},"item_3_source_id_20":{"attribute_name":"EISSN","attribute_value_mlt":[{"subitem_source_identifier":"13474839","subitem_source_identifier_type":"ISSN"}]},"item_3_version_type_32":{"attribute_name":"著者版フラグ","attribute_value_mlt":[{"subitem_version_resource":"http://purl.org/coar/version/c_970fb48d4fbd8a85","subitem_version_type":"VoR"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"Masumura, Yoshinori"}]},{"creatorNames":[{"creatorName":"Kobayashi, Akira"}]},{"creatorNames":[{"creatorName":"Yamazaki, Noboru"}]}]},"item_files":{"attribute_name":"ファイル情報","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2018-08-27"}],"displaytype":"detail","filename":"JCircJ-54-1471.pdf","filesize":[{"value":"707.9 kB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"JCircJ-54-1471.pdf","url":"https://hama-med.repo.nii.ac.jp/record/2439/files/JCircJ-54-1471.pdf"},"version_id":"c0131d14-1b64-4ecc-a254-bdc4b7cedc04"}]},"item_keyword":{"attribute_name":"キーワード","attribute_value_mlt":[{"subitem_subject":"Carnitine","subitem_subject_scheme":"Other"},{"subitem_subject":"Free carnitine","subitem_subject_scheme":"Other"},{"subitem_subject":"Long-chain acylcarnitine","subitem_subject_scheme":"Other"},{"subitem_subject":"Myocardium","subitem_subject_scheme":"Other"},{"subitem_subject":"Chronic heart failure","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"MYOCARDIAL FREE CARNITINE AND FATTY ACYLCARNITINE LEVELS IN PATIENTS WITH CHRONIC HEART FAILURE","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"MYOCARDIAL FREE CARNITINE AND FATTY ACYLCARNITINE LEVELS IN PATIENTS WITH CHRONIC HEART FAILURE","subitem_title_language":"en"}]},"item_type_id":"3","owner":"4","path":["11"],"pubdate":{"attribute_name":"PubDate","attribute_value":"2013-08-27"},"publish_date":"2013-08-27","publish_status":"0","recid":"2439","relation_version_is_last":true,"title":["MYOCARDIAL FREE CARNITINE AND FATTY ACYLCARNITINE LEVELS IN PATIENTS WITH CHRONIC HEART FAILURE"],"weko_creator_id":"4","weko_shared_id":-1},"updated":"2023-08-02T05:05:12.331242+00:00"}